Skip to main content
OpenTrials
Completed

NCT Number: NCT01698099

Diagnostic Accuracy of Serum Bilirubin in the Prediction of Perforated Appendicitis

Hyperbilirubinemia is reported to be a positive predictor in diagnosing perforated appendicitis. Therefore we analysed the diagnostic accuracy of serum bilirubin in discriminating between perforated and simple/no appendicitis.

Methods:

All consecutive patients undergoing appendectomy for suspected appendicitis from May 2009 to August 2011 were analysed. Primary endpoint was the diagnostic accuracy of serum bilirubin levels to detect perforated appendicitis.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Departement of Visceral- and Transplant Surgery, University of Tuebingen

Tübingen, 72076, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients undergoing appendectomy for suspected appendicitis

Exclusion criteria

  • preexisting liver disease

Treatment and study plan

Primary outcomes

  1. Diagnostic accuracy of serum bilirubin

    Time frame: 24h within initial presentation with clinical symptoms

    assessment of the diagnostic accuracy of hyperbilirubinemia (defined as serum bilirubin above 1.1 md/dl)

Sponsors and collaborators

Lead sponsor

University Hospital Tuebingen

Other

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2012
First posted
Oct 2, 2012
Registry last updated
Oct 2, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.